An Integrative Choice for Cancer Support in Small Animals
FREE Live Webinar on May 7th, 10am Pacific / 1pm Eastern
Register at: www.naturalpetrx.com
Guest: Dr. Nancy Scalan, DVM
Host: Geoff D\'Arcy D.O.M
6. Lung Cancer and Vegetable Intake
(each line is the results of a different study, the blue
line is the average)
2.7
2.2
Relative risk
1.7
1.2
0.7
0.2
-0.3 0 100 200 300 400 500
Vegetable intake grams/day
8. Stomach Cancer
and Fruit Intake
1.4
1.2
Relative risk
1
0.8
0.6
0.4
0 100 200 300 400 500
Fruit intake grams/day
9. NF-kappa B (NF-kB)
master switch to regulate more than 300 genes
• nuclear factor-kappa B (NF-kB), a powerful master switch known to
regulate expression of more than 300 genes that promote an
abnormal inflammatory response that leads to a variety of
disorders, these transcription factors are persistently active in a
number of disease states including
• heart disease.
• cancer.
• arthritis
• immune responses
• inflammatory responses
• chronic inflammation, IBS, chron’s, ulcerative colitis
• developmental processes, cellular growth, and apoptosis.
• asthma,
• neurodegenerative diseases
10.
11.
12.
13.
14. Refferences
1,830 PAPERS STUDIES AND REPORTS ON CURCUMIN
• Aggarwal B. Paper presented at the U.S. Defense Department's 'Era of Hope' Breast Cancer Research Program meeting in Philadelphia, PA, October 5,
2005,. reported in NUTRAingredients.com/Europe "Turmeric slows breast cancer spread in mice."
• Ahsan H, Parveen N, Khan NU, Hadi SM. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin
and bisdemethoxycurcumin. Chem Biol Interact 1999 Jul 1;121(2):161-75, PMID: 7690
• Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998 Jun;4(6):376-83, PMID: 7540
• Asai A, Nakagawa K, Miyazawa T. Antioxidative effects of turmeric, rosemary and capsicum extracts on membrane phospholipid peroxidation and liver
lipid metabolism in mice. Biosci Biotechnol Biochem 1999 Dec;63(12):2118-22, PMID: 7550
• Balasubramanian K. Molecular Orbital Basis for Yellow Curry Spice Curcumin's Prevention of Alzheimer's Disease. J. Agric. Food Chem., 54 (10), 3512 -
3520, 2006. 10.1021/jf0603533 S0021-8561(06)00353-0, Web Release Date: April 20, 2006.
• Calabrese V, Butterfield DA, Stella AM. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for
neuroprotection in Alzheimer's disease. Ital J Biochem. 2003 Dec;52(4):177-81.
• Calabrese V, et. al. Paper on curcumin's induction of hemeoxygenase-1. Presented at the annual conference of the American Physiological Society,
held April 17-21, 2004, Washington, D.C.
• Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of
adenomas in familial adenomatous polyposis. i>Clin Gastroenterol Hepatol. 2006 Aug;4(8):1035-8. Epub 2006 Jun 6. , PMID: 16757216
• Deshpande UR, Gadre SG, Raste AS, et al. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats.
Indian J Exp Biol 1998 Jun;36(6):573-7, PMID: 7740
• Dorai T, Cao YC, Dorai B, et al. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and
inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001 Jun 1;47(4):293-303, PMID: 16280
• Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ. Curcumin, a major constituent of
turmeric, corrects cystic fibrosis defects. Science. 2004 Apr 23;304(5670):600-2., PMID: 15105504
• Ensminger AH, Esminger M. K. J. e. al. Food for Health: A Nutrition Encyclopedia. Clovis, California: Pegus Press; 1986, PMID: 15210
• Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, Bernard G.
Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2005 Jun;7(3):221-32; discussion 255-62. ,
PMID: 16006665
• Fortin, Francois, Editorial Director. The Visual Foods Encyclopedia. Macmillan, New York 1996
• Grieve M. A Modern Herbal. Dover Publications, New York 1971
• Gururaj A, Kelakavadi M, Venkatesh D et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 2002 Oct
4;297(4):934 2002
• Hidaka H, Ishiko T, Furunashi T et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell
surface:impacgt on human pancrreatic carcinoma cell growth by autocrine regulation. Cancer 2002 Sep 15;96(6):1206-14 2002
• Kang BY, Chung SW, Chung W et al. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophage by curcumin. Eur J Pharmacol
1999 Nov;384(2-3):191-5 1999
15. 1,830 PAPERS STUDIES AND REPORTS ON CURCUMIN
• Kang BY, Song YJ, Kim KM et al. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J
Pharmacol 1999 Sep;128(2):380-4 1999
• Khor TO, Keum YS, Lin W, Kim JH, Hu1 R, Shen G, Xu1 C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH, Kong AN. Combined Inhibitory Effects of
Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient Mice. Cancer Research. 2006 Jan;
66(2): 613-621., PMID: 16423986
• Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci
2001 Nov 1;21(21):8370-7, PMID: 16240
• Nagabhushan M, Amonkar AJ, Bhide SV. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem Toxicol. 1987
Jul;25(7):545-7., PMID: 3623345
• Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr. 1992 Apr;11(2):192-8. , PMID: 1578097
• Nagabhushan M, Nair UJ, Amonkar AJ, D'Souza AV, Bhide SV. Curcumins as inhibitors of nitrosation in vitro. Mutat Res. 1988 Nov;202(1):163-9., PMID:
3054526
• Nagabhushan M. . Research presented at the Children with Leukaemia Conference, www.leukaemia.org, September 2004
• Nakamura K, Yasunaga Y, Segawa T et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 2002
Oct;21(4):825-30 2002
• Natarajan C, Bright JJ. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-2
prodeuction, IL-12 signaling and Th1 differentiation. Genes Immun 2002 Apr;3(2):59-70 2002
• Olszewska M, Glowacki R, Wolbis M, Bald E. Quantitative determination of flavonoids in the flowers and leaves of Prunus spinosa L. Acta Pol Pharm
2001 May-2001 Jun 30;58(3):199-203, PMID: 16270
• Parfk SY, Kim DS. Discovery of natural products from Curcuma longa that protects cells from beta-amyloid insult: a drug discovery effort against
Alzherimer's disease. J Nat Prod 2002 Sep;65(9):1227-31 2002
• Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K. Curcumin attenuates DNB-induced murine colitis. Am J Physiol
Gastrointest Liver Physiol. Jul;285(1):G235-43. Epub 2003 Mar 13 2003, PMID: 12637253
• Shah BH, Nawaz Z, Pertani SA, et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet- activating factor- and arachidonic acid-
mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signa. Biochem Pharmacol 1999 Oct 1;58(7):1167-72, PMID:
7670
• Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses
proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005 Sep 1;70(5):700-13., PMID: 16023083
• Wills RB, Scriven FM, Greenfield H. Nutrient composition of stone fruit (Prunus spp.) cultivars: apricot, cherry, nectarine, peach and plum. J Sci Food
Agric 1983 Dec;34(12):1383-9, PMID: 16280
• Wood, Rebecca. The Whole Foods Encyclopedia. New York, NY: Prentice-Hall Press; 1988, PMID: 15220
• Wuthi-udomler M, Grisanapan W, Luanratana O, Caichompoo W. Antifungal activity of Curcuma longa grown in Thailand. Southeast Asian J Trop Med
Public Health 2000;31 Suppl 1:178-82, PMID: 16270
• Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation
of Abeta oligomers and fibrils and binds plaques and reduces amyloid in vivo. J Biol Chem. 2004 Dec 7; [Epub ahead of print], PMID: 15590663
• Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M. Curcuminoids enhance
amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2006 Sep;10(1):1-7., PMID: 16988474
16. Sulforaphane in Broccoli
• Sulforaphane induces Phase 2 (detoxification) enzymes,
which are the enzymes that help to deactivate carcinogens
and free radicals, thereby enhancing the body's own defense
system.
• Some of the best growing techniques now guarantee large
quantities, up to 5,500 parts per million, of sulforaphane
within organically grown broccoli sprout
• In animal studies, sulforaphane blocked tumor development,
reducing incidence, multiplicity, and size of carcinogen-
induced mammary tumors
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Conventional scientific databases contain hundreds of references to “power” mushrooms. In China, cancer research and treatment are showing they can help counteract the toxic effects of chemotherapy and radiation while increasing outcomes against control groups not using herbs. Reishi nourishes the immune system, boosting the life span of white blood cells; its polysaccharides are anti-tumor, anti-viral and boost T-cell function. Maitake targets breast and colorectal cancers. It is very effective for helping the immune system rebound from chemotherapy. Polysaccharide compounds from Shiitake that exhibited strong anti-tumor activities. maximize a host-mediated response to awaken the immune system, a panoply of mushroom polysaccharides is best. “ Modern scientific studies of the medicinal mushrooms have expanded exponentially during the last two decades primarily in Japan, Korea and China but also in the USA and scientific explanations of how these compounds function in the animal and human systems are increasingly appearing in peer-reviewed scientific and medical journals.” “ Mushroom-derived polysaccharides are now considered as compounds which are able to modulate animal and human immune responses and to inhibit certain tumour growths.“ While mushroom glucans are mostly non-cytotoxic, the same is not true of glucan-protein complexes. All of these compounds, however, have been shown to potentiate the host’s innate (non-specific) and acquired (specific) immune responses and activate many kinds of immune cells that are important for the maintenance of homeostasis, e.g. host cells (such as cytotoxic macrophages, monocytes, neutrophils, natural killer cells, dendritic cells) and chemical messengers (cytokines such as interleukins, interferons, colony stimulating factors) that trigger complement and acute phase responses. Also, they can be considered as multi-cytokine inducers able to induce gene expression of various immunomodulatory cytokines and cytokine receptors. Lymphocytes governing antibody production (β-cells) and cell-mediated cytotoxicity (T-cells) are also stimulated.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”
Boom in Pet Health Insurance: Embrace Pet Insurance, Fetch, Inc., EnsuraPet, Trupanion and Nestlé Purina PetCare—joining established players including Veterinary Pet Insurance, Pethealth, SecuriCan, Hartville (APSCA) and Vetinsurance Ltd. In addition, three companies that were just getting started in the U.S. market in 2005—Pets Best, PetFirst and PetPartners (American Kennel Club)—are now established. All of these companies bring to the market unique strengths, including potent co-marketing affiliations with powerful pet market brands. Joint supplements – No. 1 type of dog supplement: Accounting for 30% of sales in 2007, according to Packaged Facts’ February 2008 report, Pet Supplements and Nutraceutical Treats in the U.S. Continued Growth through 2012 at $1.7Billion – Age-Related, Weight-Management, Flea/Tick, Prebiotics/Probiotics: Packaged Facts forecasts continued healthy growth for pet supplements and nutraceutical treats through 2012, when sales are expected to reach $1.7 billion, with certain segments making an especially strong showing, including age-related products, weight-related products, flea/tick care supplements, emerging ingredients such as prebiotics/probiotics, omega fatty acids, whole fruits and vegetables, and soy protein and isoflavones. Complimentary Medicine More Mainstream: As Robert E. Devlin, DVM, Veterinary Products Marketing Manager at leading veterinary supplement maker Nutramax Laboratories, Inc., told Veterinary Practice News (July 2007), “There’s a growing awareness and acceptance of complimentary medicine. It’s becoming more mainstream. Influx of Younger Female Veterinarians who are more open to complementary methods Expanding array of condition-specific products Growing number of specialties of pain management and senior pet care Success of the supplements industry in providing products that are safe and efficacious Growing range of scientific studies and clinical tests backing the products Increasing focus across advertising for “vet-exclusive” products Long-term administration of traditional non-steroidal anti-inflammatory medications can induce gastrointestinal toxicity, kidney failure and liver disease. Rising costs of such medications Growing number of veterinarians are turning to supplements in treating pets with cancer, which may not be able to tolerate traditional drug therapies. As Robert Silver, DVM, Director of Boulder’s Natural Animal Integrative Wellness Center and CEO of Rx Vitamins for Pets told Veterinary Practice News (March 2007), “Certainly in patients that, for one reason or another, are not viable candidates for chemo or radiation, the use of nutraceutical and botanical therapies improves patient quality of life.”